secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001104659-23-106102
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics announces 2023 annual meeting voting results; directors elected, auditor ratified
--------------------------------------------------------------------------------

- Four directors elected: Kraws, Shallcross, Monahan, Wolf; votes for ranged from 1,996,551 to 2,553,173, with 4,077,933 broker non-votes each.
- Ratification of BDO USA P.C. as independent auditor for FY 2023: 7,059,989 for, 171,037 against, 182,495 abstentions.
- Meeting held October 2, 2023; no other proposals voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465923106102/0001104659-23-106102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465923106102/tm2327462d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-106102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer